Valve Sparing Root Replacement Provides Similar Midterm Outcomes in Bicuspid and Trileaflet Valves
| Autor: | LaRonica McPherson, Michael O. Kayatta, Chao Zhang, Bradley G. Leshnower, Yi Lasanajak, Edward P. Chen |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty Aortic root Aortic Valve Insufficiency Treatment outcome Heart Valve Diseases 030204 cardiovascular system & hematology Cohort Studies 03 medical and health sciences 0302 clinical medicine Bicuspid aortic valve Bicuspid Aortic Valve Disease Aortic valve replacement Patient age Bicuspid valve Internal medicine Humans Medicine In patient cardiovascular diseases Survival rate Heart Valve Prosthesis Implantation business.industry Middle Aged medicine.disease Survival Rate Treatment Outcome 030228 respiratory system Aortic Valve cardiovascular system Cardiology Female Surgery Cardiology and Cardiovascular Medicine business |
| Zdroj: | The Annals of Thoracic Surgery. 107:54-60 |
| ISSN: | 0003-4975 |
| DOI: | 10.1016/j.athoracsur.2018.07.045 |
| Popis: | Valve-sparing aortic root replacement (VSRR) is an established treatment for aortic root pathology for trileaflet valves. The safety and durability of VSRR in bicuspid aortopathy is unclear. In this study, outcomes of performing VSRR in the setting of bicuspid and trileaflet valves were compared.An institutional database identified 294 patients who underwent VSRR from 2005 to 2017. Of these, 225 had trileaflet valves and 69 had bicuspid valves. Patients were followed prospectively and had annual postoperative echocardiograms. Propensity-matched comparisons were made between trileaflet and bicuspid valve patients.The average patient age for trileaflet valves was 46.0 ± 13.5 versus 42.7 ± 12.2 years for bicuspid patients (p = 0.07). There was a higher presence of preoperative2+ aortic insufficiency (AI) present in bicuspid patients (63.8%) compared with trileaflet patients (31.1%) (p0.01). Mean follow-up was 39 months and was 98% complete. At 5 years, the cumulative incidence of2+ AI and aortic valve replacement (AVR) was 2.0% and 4.3% in trileaflet patients and 7.7% (p = 0.75) and 7.7% (p = 0.81) in bicuspid patients. Preoperative2+ AI was not predictive of2+ postoperative AI (p = 0.62) nor AVR (p = 0.49). Five-year survival was no different between groups (trileaflet: 98%, bicuspid: 84%, p = 0.24).VSRR can be safely and effectively performed in patients with trileaflet and bicuspid valves. Operative outcomes and valve function were equivalent in bicuspid and trileaflet patients in midterm follow-up. Performance of VSRR is a viable term option in the setting bicuspid aortic valve aortopathy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|